Provided by Tiger Trade Technology Pte. Ltd.

Jaguar Animal Health

0.7911
-0.0188-2.32%
Post-market: 0.79920.0081+1.02%19:30 EDT
Volume:48.15K
Turnover:37.42K
Market Cap:3.88M
PE:0.00
High:0.7998
Open:0.7856
Low:0.7503
Close:0.8099
52wk High:77.63
52wk Low:0.7250
Shares:4.91M
Float Shares:4.88M
Volume Ratio:0.28
T/O Rate:0.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-262.2873
EPS(LYR):-803.9466
ROE:-548.83%
ROA:-38.04%
PB:0.59
PE(LYR):0.00

Loading ...

Jaguar Health advances extension phase of pivotal oral crofelemer trial in pediatric MVID patients

Reuters
·
May 28

Jaguar Health regains compliance with Nasdaq Listing Rule

TIPRANKS
·
May 27

Jaguar Health regains Nasdaq compliance with $1 minimum bid price rule

Reuters
·
May 27

Jaguar Animal Health Adjourns 2026 Annual Shareholder Meeting

TIPRANKS
·
May 23

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM

Reuters
·
May 21

Jaguar Health Q1 EPS $(13.60) Misses $(4.26) Estimate, Sales $20.272M Beat $4.211M Estimate

Benzinga Earnings
·
May 21

Jaguar Health Inc - Q1 Net Revenue $20.3 Mln- SEC Filing

THOMSON REUTERS
·
May 21

Jaguar Health turns to Q1 profit; revenue more than doubled to $20.27 million

Reuters
·
May 21

Jaguar Health publishes financial calendar update

Reuters
·
May 20

Jaguar Animal Health Issues Series Q Preferred Stock

TIPRANKS
·
May 20

Jaguar Health exchanges Series Q preferred for $22.7 million royalty interest reduction

Reuters
·
May 20

Jaguar says first patient from pediatric MVID entered active treatment

TIPRANKS
·
May 19

Jaguar Health extends pivotal MVID crofelemer trial into active-treatment phase

Reuters
·
May 19

Jaguar Health delays quarterly report filing after subsequent event transaction review

Reuters
·
May 19

Jaguar Health wins Nasdaq extension to regain $1 bid price compliance by May 18

Reuters
·
May 08

Jaguar Health discusses FDA breakthrough pathway for crofelemer in pediatric MVID trial

Reuters
·
May 06

Jaguar Animal Health Faces New Nasdaq Compliance Deficiency

TIPRANKS
·
May 04

Jaguar Health risks Nasdaq delisting after reverse split cuts public float below 500,000 shares

Reuters
·
May 04

Jaguar Animal Health trading halted, news pending

TIPRANKS
·
Apr 30

Jaguar Health announces results from trial of crofelemer

TIPRANKS
·
Apr 29